Ketone Bodies and Cardiovascular Disease: An Alternate Fuel Source to the Rescue

The increased metabolic activity of the heart as a pump involves a high demand of mitochondrial adenosine triphosphate (ATP) production for its mechanical and electrical activities accomplished mainly via oxidative phosphorylation, supplying up to 95% of the necessary ATP production, with the rest a...

Full description

Bibliographic Details
Main Authors: Antonis S. Manolis, Theodora A. Manolis, Antonis A. Manolis
Format: Article
Language:English
Published: MDPI AG 2023-02-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/24/4/3534
_version_ 1797620523176296448
author Antonis S. Manolis
Theodora A. Manolis
Antonis A. Manolis
author_facet Antonis S. Manolis
Theodora A. Manolis
Antonis A. Manolis
author_sort Antonis S. Manolis
collection DOAJ
description The increased metabolic activity of the heart as a pump involves a high demand of mitochondrial adenosine triphosphate (ATP) production for its mechanical and electrical activities accomplished mainly via oxidative phosphorylation, supplying up to 95% of the necessary ATP production, with the rest attained by substrate-level phosphorylation in glycolysis. In the normal human heart, fatty acids provide the principal fuel (40–70%) for ATP generation, followed mainly by glucose (20–30%), and to a lesser degree (<5%) by other substrates (lactate, ketones, pyruvate and amino acids). Although ketones contribute 4–15% under normal situations, the rate of glucose use is drastically diminished in the hypertrophied and failing heart which switches to ketone bodies as an alternate fuel which are oxidized in lieu of glucose, and if adequately abundant, they reduce myocardial fat delivery and usage. Increasing cardiac ketone body oxidation appears beneficial in the context of heart failure (HF) and other pathological cardiovascular (CV) conditions. Also, an enhanced expression of genes crucial for ketone break down facilitates fat or ketone usage which averts or slows down HF, potentially by avoiding the use of glucose-derived carbon needed for anabolic processes. These issues of ketone body utilization in HF and other CV diseases are herein reviewed and pictorially illustrated.
first_indexed 2024-03-11T08:42:45Z
format Article
id doaj.art-37c7e632761d47ceb5cff74d9cbaf339
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-11T08:42:45Z
publishDate 2023-02-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-37c7e632761d47ceb5cff74d9cbaf3392023-11-16T21:01:24ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672023-02-01244353410.3390/ijms24043534Ketone Bodies and Cardiovascular Disease: An Alternate Fuel Source to the RescueAntonis S. Manolis0Theodora A. Manolis1Antonis A. Manolis2School of Medicine, Athens University, 115 27 Athens, GreeceSchool of Medicine, Athens University, 115 27 Athens, GreeceSchool of Medicine, Patras University, 265 04 Patras, GreeceThe increased metabolic activity of the heart as a pump involves a high demand of mitochondrial adenosine triphosphate (ATP) production for its mechanical and electrical activities accomplished mainly via oxidative phosphorylation, supplying up to 95% of the necessary ATP production, with the rest attained by substrate-level phosphorylation in glycolysis. In the normal human heart, fatty acids provide the principal fuel (40–70%) for ATP generation, followed mainly by glucose (20–30%), and to a lesser degree (<5%) by other substrates (lactate, ketones, pyruvate and amino acids). Although ketones contribute 4–15% under normal situations, the rate of glucose use is drastically diminished in the hypertrophied and failing heart which switches to ketone bodies as an alternate fuel which are oxidized in lieu of glucose, and if adequately abundant, they reduce myocardial fat delivery and usage. Increasing cardiac ketone body oxidation appears beneficial in the context of heart failure (HF) and other pathological cardiovascular (CV) conditions. Also, an enhanced expression of genes crucial for ketone break down facilitates fat or ketone usage which averts or slows down HF, potentially by avoiding the use of glucose-derived carbon needed for anabolic processes. These issues of ketone body utilization in HF and other CV diseases are herein reviewed and pictorially illustrated.https://www.mdpi.com/1422-0067/24/4/3534ketone bodiesbeta-hydroxybutyrateacetoacetateacetonecardiovascular diseaseheart failure
spellingShingle Antonis S. Manolis
Theodora A. Manolis
Antonis A. Manolis
Ketone Bodies and Cardiovascular Disease: An Alternate Fuel Source to the Rescue
International Journal of Molecular Sciences
ketone bodies
beta-hydroxybutyrate
acetoacetate
acetone
cardiovascular disease
heart failure
title Ketone Bodies and Cardiovascular Disease: An Alternate Fuel Source to the Rescue
title_full Ketone Bodies and Cardiovascular Disease: An Alternate Fuel Source to the Rescue
title_fullStr Ketone Bodies and Cardiovascular Disease: An Alternate Fuel Source to the Rescue
title_full_unstemmed Ketone Bodies and Cardiovascular Disease: An Alternate Fuel Source to the Rescue
title_short Ketone Bodies and Cardiovascular Disease: An Alternate Fuel Source to the Rescue
title_sort ketone bodies and cardiovascular disease an alternate fuel source to the rescue
topic ketone bodies
beta-hydroxybutyrate
acetoacetate
acetone
cardiovascular disease
heart failure
url https://www.mdpi.com/1422-0067/24/4/3534
work_keys_str_mv AT antonissmanolis ketonebodiesandcardiovasculardiseaseanalternatefuelsourcetotherescue
AT theodoraamanolis ketonebodiesandcardiovasculardiseaseanalternatefuelsourcetotherescue
AT antonisamanolis ketonebodiesandcardiovasculardiseaseanalternatefuelsourcetotherescue